Envisia

Graybug Vision

The company develops sustained-release injectable medicines for patients with retinal diseases and glaucoma to reduce the frequency of ocular treatments.

INEYE Therapeutics

This company develops ocular drug delivery inserts to treat chronic eye conditions such as dry eye and glaucoma for patients.

Perfuse Therapeutics

The company develops sustained-release intravitreal therapies to treat ischemia-driven ocular diseases for patients with conditions like glaucoma and diabetic retinopathy.

Biophta

This company develops self-administered ocular inserts providing seven-day continuous drug release for patients with glaucoma and macular oedema.

Tavo Biotherapeutics

The company develops topical and injectable treatments for patients with glaucoma and retinal diseases.

Eyexora

This company develops therapeutics and medical devices for ophthalmic diseases to treat patients with vision-threatening conditions.

SpyGlass Pharma, Inc

The company develops an intraocular lens drug delivery system for patients with glaucoma to provide long-term medication during cataract surgery.

Oculis

This biopharmaceutical company develops topical therapies and delivery systems to treat neuro-ophthalmic and ophthalmic diseases for patients with unmet medical needs.